东北制药:聘任李新为公司财务总监

Group 1 - Northeast Pharmaceutical announced the appointment of Li Xin as the Chief Financial Officer after approval from the board's nomination committee and audit committee [1] - For the first half of 2025, Northeast Pharmaceutical's revenue composition is as follows: 52.0% from pharmaceutical manufacturing, 46.18% from pharmaceutical commerce, and 1.82% from other industries [1] - As of the report date, Northeast Pharmaceutical has a market capitalization of 8.1 billion [1]